GlassScriptPhysician profile
Jason K Luttrell
NPI 1851664098
$7,330.65
in general payments reported to CMS, 2019-2025
21 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,157 · 2020: $714 · 2021: $882 · 2022: $1,195 · 2023: $1,151 · 2024: $1,216 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,201 · Long Term Medical Supply Or Device Loan: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,200.96 |
| Long Term Medical Supply Or Device Loan | $181.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,889.34 | 2019-2025 | Actishield, Viaflow, Hoffmann |
| Integra Lifesciences Corporation | $1,653.75 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $861.82 | 2019-2024 | Renasys Go V2 Home, Collagenase Santyl, Regranex |
| Aroa Biosurgery Incorporated | $829.92 | 2024-2025 | |
| Stability Biologics, LLC | $440.88 | 2020-2022 | |
| Next Science LLC | $312.15 | 2022-2023 | Surgx, Blastx, Xperience |
| Paratek Pharmaceuticals, INC. | $297.37 | 2022-2025 | Nuzyra |
| Organogenesis INC. | $177.25 | 2019-2022 | |
| Stimwave Technologies Incorporated | $174.30 | 2021-2022 | |
| Medtronic, INC. | $145.47 | 2022 | |
| Surgenex LLC | $125.25 | 2025 | Pellograft, Surmatrix, Ardeograft |
| Convatec INC. | $99.07 | 2023 | |
| Sebela Pharmaceuticals INC. | $72.59 | 2019 | |
| Kci USA, INC. | $60.21 | 2019-2023 | Kerramax Care, Activ.A.C. |
| Kerecis Limited | $54.69 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $27.97 | 2025 | Bio-Connekt |
| Access Pro Medical, LLC | $26.19 | 2023 | Matriderm |
| Bioventus LLC | $25.97 | 2023 | |
| Lifenet Health | $23.72 | 2024 | Theragenesis Wound Matrix |
| Grt US Holding, INC. | $19.55 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Luttrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.